HOME › DRUGS › SIPONIMOD
ACTIVE SUBSTANCE / INN

SIPONIMOD

Brand name(s): Mayzent, MAYZENT, SIPONIMOD
FDA LISTED
EMA LISTED
PRESCRIPTION
DISCONTINUED
AUTHORISED
ANDA218393
ANDA218444
ACTIVE SUBSTANCE
Siponimod
REGULATORS
FDA · EMA
SPONSORS / MAH
RICONPHARMA LLC, AUROBINDO PHARMA LTD, NOVARTIS
TOTAL APPLICATIONS
5
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
SIPONIMODANDA218444RICONPHARMA LLCDiscontinued
MAYZENTNDA209884NOVARTISPrescription
SIPONIMODANDA218459AUROBINDO PHARMA LTDPrescription
SIPONIMODANDA218393DR REDDYS LABS LTDNone (Tentative Approval)
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
MayzentNovartis Europharm LimitedAuthorised13/01/2020Multiple Sclerosis, Relapsing-Remitting

FULL INTELLIGENCE ON SIPONIMOD

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →